Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations section was updated: new site locations including California, Connecticut, Florida, Georgia, Idaho, New Jersey, Tennessee, Texas, Virginia, and Quebec were added and the revision updated to v3.3.3. The corresponding location subsections (California Locations, Connecticut Locations, Florida Locations, Georgia Locations, Idaho Locations, New Jersey Locations, Tennessee Locations, Texas Locations, Virginia Locations, Quebec Locations) were removed, and the HHS Vulnerability Disclosure entry was deleted.SummaryDifference0.5%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedAdded a note that publications are automatically filled in from PubMed (Revision: v3.3.2). Replaced the prior PubMed-based description with updated wording reflecting automatic listing (Revision: v3.2.0).SummaryDifference0.0%

- Check55 days agoChange DetectedThe government funding lapse notice banner that used to appear on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedUpdated the study location name from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'.SummaryDifference0.0%

- Check70 days agoChange DetectedNo substantial content changes detected between the screenshots; core sections such as Study Overview, Eligibility Criteria, and Locations appear unchanged. Only minor formatting differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check98 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.